Factor VIII – Baxter: rAHF-PFM, Recombinant Anti-Haemophilic Factor – Protein-Free Method, Recombinant Factor VIII – Protein-Free

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 366-368

Adis International

Access to resources Recommend Favorite

Immunogenicity and pharmacokinetic studies of recombinant Factor VIII containing lipid cochleates

By Kosloski Matthew P.   Peng Aaron   Varma Prashant R.   Fathallah Anas M.   Miclea Razvan D.   Mager Donald E.   Balu-iyer Sathy V.  

Drug Delivery, Vol. 18, Iss. 4, 2011-05 ,pp. : 246-254

Informa Healthcare

Access to resources Recommend Favorite

Population pharmacokinetics of recombinant factor VIII Fc fusion protein

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 163-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solid state 'adsorption' of fine antibiotic powders onto sorbitol: effects of particle size, state of sorbed water and surface free energy characteristics

By Nikolakakis I.   Newton J.M.   Malamataris S.  

European Journal of Pharmaceutical Sciences, Vol. 17, Iss. 4, 2002-12 ,pp. : 229-238

Elsevier

Access to resources Recommend Favorite

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX

By Lyseng-Williamson Katherine A.   Plosker Greg L.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1007-1029

Adis International

Access to resources Recommend Favorite